ArticleHepatology (Baltimore, Md.)2018

Fibroblast Growth Factor Receptor Inhibition for Cholangiocarcinoma: Looking Through a Door Half-Opened.

Sumera I Ilyas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.